Abrdn Healthcare Investors
HQL
Rank in Stocks
#7749
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and... Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Share Price
$18.66
Last synced: 2026-11-09
Market Cap
$1.25B
Change (1 day)
3.15%
Change (1 year)
11.34%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Abrdn Healthcare Investors (HQL)
Category
Financial Services
EPS for Abrdn Healthcare Investors (HQL)
EPS as of March 2026 TTM: $6.75
According to Abrdn Healthcare Investors's latest financial reports, its current EPS (TTM) is $6.75. At the end of 2025 the company had an EPS of $2.96, a decrease compared to its 2024 EPS of $3.04.
EPS history for Abrdn Healthcare Investors from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $6.75 | 128.04% |
| 2025 | $2.96 | -2.63% |
| 2024 | $3.04 | 284.81% |
| 2023 | $0.79 | -119.41% |
| 2022 | $-4.07 | -253.01% |
| 2021 | $2.66 | -48.45% |
| 2020 | $5.16 | -269.74% |
| 2019 | $-3.04 | -337.50% |
| 2018 | $1.28 | -60.12% |
| 2017 | $3.21 | -421.00% |
| 2016 | $-1.00 | -148.54% |
| 2015 | $2.06 | -56.17% |
| 2014 | $4.70 | -16.81% |
| 2013 | $5.65 | 5.02% |
| 2012 | $5.38 | 109.34% |
| 2011 | $2.57 | 446.81% |
| 2010 | $0.47 | -147.47% |
| 2009 | $-0.99 | -134.62% |
| 2008 | $2.86 | 13.49% |
| 2007 | $2.52 | -327.03% |
| 2006 | $-1.11 | -131.27% |
| 2005 | $3.55 | 501.69% |
| 2004 | $0.59 | -82.54% |
| 2003 | $3.38 | -169.83% |
| 2002 | $-4.84 | -52.55% |
| 2001 | $-10.20 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $44.57 | 560.30% |
US
|
|
| $4.53 | -32.89% |
US
|
|
| $7.07 | 4.80% |
SE
|
|
| $3.36 | -50.22% |
US
|
|
| $0.35 | -94.81% |
US
|
Questions about Abrdn Healthcare Investors's earnings per share (EPS)
What is Abrdn Healthcare Investors's earnings per share (EPS)?
Abrdn Healthcare Investors's earnings per share (EPS) over the last twelve months is $6.75, as of Mar 2026.
What was Abrdn Healthcare Investors's earnings per share (EPS) in 2025?
In 2025, Abrdn Healthcare Investors's earnings per share (EPS) was $2.96, 2.63% less than in 2024 ($3.04).
How has Abrdn Healthcare Investors's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Abrdn Healthcare Investors's earnings per share (EPS) went from $5.16 to $2.96, an average decline of 10.52% a year.
How does Abrdn Healthcare Investors's earnings per share (EPS) compare with similar companies?
Abrdn Healthcare Investors's earnings per share (EPS) ($6.75) is higher than that of 3 of the 5 similar companies listed above. The highest among them is BlackRock, Inc., with $44.57.